| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.76(B) |
| Last
Volume: |
1,423,724 |
Avg
Vol: |
1,912,482 |
| 52
Week Range: |
$65.11 - $87.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 317 |
| Guru Rank Value : 4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
26,945 |
123,113 |
125,503 |
386,163 |
| Total Sell Value |
$2,043,551 |
$8,902,469 |
$9,102,584 |
$28,910,482 |
| Total People Sold |
3 |
6 |
6 |
11 |
| Total Sell Transactions |
3 |
8 |
9 |
19 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Griffin John M. |
General Counsel |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,150 |
173,002 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,029 |
107,531 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,272 |
73,028 |
|
- |
|
| Daugherty Sean S. |
Group President, BSH & Surg. |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,272 |
58,701 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,108 |
19,004 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,146 |
2,459,188 |
|
- |
|
| Hellmann Elisabeth A |
SVP, Human Resources |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,108 |
9,053 |
|
- |
|
| Thornal Kevin R |
Div. President, Diagnostics |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,150 |
68,130 |
|
- |
|
| Daugherty Sean S. |
Group President, BSH & Surg. |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,816 |
53,429 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
43,252 |
166,852 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
240,732 |
2,424,042 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,087 |
67,756 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
43,424 |
100,502 |
|
- |
|
| Thornal Kevin R |
Div. President, Diagnostics |
• • – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,764 |
61,980 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2021-08-10 |
4 |
S |
$77.49 |
$387,425 |
D/D |
(5,000) |
16,896 |
|
-1% |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2021-08-10 |
4 |
OE |
$37.64 |
$188,200 |
D/D |
5,000 |
21,896 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2021-08-09 |
4 |
S |
$75.62 |
$2,017,768 |
D/D |
(26,683) |
123,600 |
|
-3% |
|
| Griffin John M. |
General Counsel |
• • – |
2021-08-09 |
4 |
OE |
$37.64 |
$1,004,348 |
D/D |
26,683 |
150,283 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2021-07-01 |
4 |
D |
$67.99 |
$23,864 |
D/D |
(351) |
44,669 |
|
- |
|
| Daugherty Sean S. |
Group President, BSH & Surg. |
• • – |
2021-05-10 |
4 |
S |
$65.02 |
$260,149 |
D/D |
(4,001) |
26,613 |
|
-19% |
|
| Crawford Sally |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
128,325 |
|
- |
|
| Stamoulis Christiana |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
40,870 |
|
- |
|
| Hantson Ludwig |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
6,490 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
3,695 |
|
- |
|
| Nawana Namal |
Director |
• • – |
2021-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,478 |
15,191 |
|
- |
|
1696 Records found
|
|
Page 8 of 68 |
|
|
0.51 (0.67%) 
